Related Experiment Video

Updated: Jun 1, 2026

A Quantitative Measurement of Reactive Oxygen Species and Senescence-associated Secretory Phenotype in Normal Human Fibroblasts During Oncogene-induced Senescence
13:59

A Quantitative Measurement of Reactive Oxygen Species and Senescence-associated Secretory Phenotype in Normal Human Fibroblasts During Oncogene-induced Senescence

Published on: August 12, 2018

Novel ARF/p53-independent senescence pathways in cancer repression

Chia-Hsin Chan1, Yuan Gao, Asad Moten

  • 1Department of Molecular and Cellular Oncology, The University of Texas, MD Anderson Cancer Center, Houston, TX 77030, USA.

Journal of Molecular Medicine (Berlin, Germany)
|May 20, 2011
PubMed

Insights

Cellular senescence acts as a cancer barrier via the ARF/p53 pathway. New research explores ARF/p53-independent senescence, offering novel cancer therapy strategies.

Area of Science:

  • Oncology
  • Cell Biology
  • Molecular Biology

Background:

  • Cellular senescence is a stress response causing irreversible cell cycle arrest.
  • Senescence acts as a tumor suppressor, notably through the ARF/p53 pathway.
  • Oncogenic insults like Ras overexpression or PTEN inactivation induce senescence, restricting cancer progression.

Purpose of the Study:

  • To investigate the role of cellular senescence in cancer development.
  • To explore the ARF/p53-dependent and independent pathways in senescence.
  • To identify novel therapeutic strategies for cancer based on senescence.

Main Methods:

  • Review of recent studies on cellular senescence and cancer.
  • Analysis of the ARF/p53 pathway's role in tumor suppression.
  • Investigation of novel regulators of ARF/p53-independent senescence.

Main Results:

  • Cellular senescence, particularly via ARF/p53, is a critical barrier to cancer.
  • ARF/p53 deficiency or mutation in cancers compromises senescence-mediated tumor suppression.
  • Novel ARF/p53-independent senescence pathways have been discovered.

Conclusions:

  • The ARF/p53 pathway is crucial for senescence-induced tumor suppression.
  • Therapeutic targeting of p53 faces challenges due to frequent mutations in cancer.
  • ARF/p53-independent senescence offers promising alternative avenues for cancer therapy.

More Related Videos

Techniques to Induce and Quantify Cellular Senescence06:51

Techniques to Induce and Quantify Cellular Senescence

Published on: May 1, 2017

SA-β-Galactosidase-Based Screening Assay for the Identification of Senotherapeutic Drugs07:39

SA-β-Galactosidase-Based Screening Assay for the Identification of Senotherapeutic Drugs

Published on: June 28, 2019

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Replicative Cell Senescence02:15

Replicative Cell Senescence

Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds the telomeric...
Replicative Cell Senescence02:15

Replicative Cell Senescence

Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds the telomeric...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...